About Group Pharmaceuticals Ltd
The company has 739 employees. Group Pharmaceuticals Ltd offers products and services including Oral Care Products and Multi-Speciality Products.
- Employees 739
- SectorsHealthcare
- Phone•••• ••••
- Social LinkedIn X Facebook YouTube
- Legal Name Group Pharmaceuticals Ltd
- Date of Incorporation 24 Jul, 1980
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹168 Cr
FY 2025 · +10% YoY
- Net Profit₹10.44 Cr
FY 2025 · 6% margin
- EBITDA₹15.78 Cr
FY 2025 · 9% margin
- Employee Count739
Associated legal entities of Group Pharmaceuticals Ltd
Group Pharmaceuticals Ltd operates through Group Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Group Pharmaceuticals Limited CIN U24239MH1980PLC022889 | Active | 24 Jul 1980 | Thane, Maharashtra | ₹168 Cr | 739 | 9 | View details |
Products & Services of Group Pharmaceuticals Ltd
Group Pharmaceuticals Ltd offers a comprehensive portfolio of products and services, including Oral Care Products and Multi-Speciality Products.
Products for specific dental and oral conditions are developed and manufactured to address consumer needs.
Products such as cough syrups and anti-bacterial gels are produced for general healthcare applications.
Apps and channels of Group Pharmaceuticals Ltd
its YouTube channel Group Pharma has 9.07K subscribers and 30 videos.
Videos from Group Pharmaceuticals Ltd
The most watched videos on Group Pharmaceuticals Ltd's YouTube channel, Group Pharma (9.07K subscribers). Click a video to play it here.
More on Group Pharma.
Board of directors of Group Pharmaceuticals Limited (Group Pharmaceuticals Ltd)
Group Pharmaceuticals Limited is the primary company behind Group Pharmaceuticals Ltd. The board of Group Pharmaceuticals Limited currently have 7 directors; the longest-serving is Ann Valerie Sunil Attavar, appointed in 2008. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ann Valerie Sunil Attavar DIN 00091390 | Whole-time director | 15 Sep 2008 | 18 yrs | Group Pharmaceuticals Limited |
| Sunil Attavar Cajaten DIN 00091347 | Nodal Officer | 17 Sep 2019 | 7 yrs | Group Pharmaceuticals Limited |
| Deepak Mohan DIN 07825780 | Managing Director | 24 May 2024 | 2 yrs 4 mo | Group Pharmaceuticals Limited |
| Jacob Mathew DIN 00996521 | Director | 24 May 2024 | 2 yrs 4 mo | Group Pharmaceuticals Limited |
| Srinivas Gogineni DIN 07231858 | Director | 08 Aug 2024 | 2 yrs 2 mo | Group Pharmaceuticals Limited |
| Nandipur Kallappa Dilip DIN 05221838 | Director | 08 Aug 2024 | 2 yrs 2 mo | Group Pharmaceuticals Limited |
| Nikhil Kaushik DIN 00040403 | Additional Director | 29 Sep 2025 | 1 yr | Group Pharmaceuticals Limited |
Financials of Group Pharmaceuticals Ltd
Figures of Group Pharmaceuticals Limited, the primary company behind Group Pharmaceuticals Ltd, for FY 2025. Revenue was ₹168 Cr (+10% year on year). Net profit was ₹10.44 Cr (6% margin). EBITDA was ₹15.78 Cr (9% margin). Revenue has grown at a compounded annual rate of +9% over three years and +6% over five years.
- ₹168 CrRevenue · FY 2025 · +10% YoY
- ₹10.44 CrNet profit · 6% margin
- ₹15.78 CrEBITDA · 9% margin
- ₹12.68 CrPaid-up capital
- 739Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Group Pharmaceuticals Limited are on its company page.
Detailed financial statements for Group Pharmaceuticals Ltd
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Group Pharmaceuticals Ltd
Websites that share an audience with Group Pharmaceuticals Ltd (grouppharma.in).
Websites whose visitors overlap most with Group Pharmaceuticals Ltd. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medipol.in | 62% | – | – | View details |
Similar companies to Group Pharmaceuticals Ltd
10 companies that operate in the same segment as Group Pharmaceuticals Ltd (Dental Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Custom 3D printed dental aligners are developed for teeth straightening. | 2017 | New York, New York, United States | USD 147.78 M | – | – | |
Invisalign clear aligners and dental products are developed. | 1997 | Tempe, Arizona, United States | USD 101 M | – | 1,051 | |
Provider of 3D ear scanning systems | 2000 | Copenhagen, Denmark | USD 36.01 K | – | 1 | |
Dental implants and regenerative dentistry products are developed. | 1954 | Basel, Basel-stadt, Switzerland | – | USD 3.29 B | – | |
Optical equipment for micron-level surface geometry capture is offered. | 2011 | Waltham, Massachusetts, United States | USD 16.22 M | – | – | |
Dental implant solutions are provided for patients and professionals. | 2000 | Harrogate, United Kingdom | USD 30.01 M | – | – | |
Dental implants and biomaterials are developed by Keystone Dental. | 2006 | Burlington, Vermont, United States | USD 86.24 M | – | – | |
Therapy devices and software for treating tooth decay are developed. | 2006 | Laguna Hills, California, United States | USD 285.41 M | USD 28.55 M | 131 | |
Invisible braces and oral care products are developed and provided. | 2018 | Singapore, Singapore | USD 55.1 M | – | – | |
Implants for dental and spine treatments are developed. | 2022 | Westminster, United States | – | USD 449.75 M | 1,770 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Group Pharmaceuticals Ltd
Group Pharmaceuticals Ltd has 739 employees.
The primary company behind Group Pharmaceuticals Ltd, Group Pharmaceuticals Limited, reported revenue of ₹168 Cr for FY 2025, up 10% year on year.
Group Pharmaceuticals Ltd is noted for its 40 years of expertise in oral well-being and healthcare, where products are developed, manufactured, and exported to over 60 countries. A workforce of more than 800 individuals is employed to deliver specialized oral care items, with innovations including 10 first-time products in India. Certifications such as ISO, cGMP, and WHO are maintained, and initiatives like Abhaya are implemented to address womens oral health issues. The companys approach involves a full product lifecycle, ensuring formulations are updated based on ongoing research and global partnerships.
Group Pharmaceuticals Ltd offers Oral Care Products and Multi-Speciality Products.
Group Pharmaceuticals Ltd operates through Group Pharmaceuticals Limited.
The legal entities of Group Pharmaceuticals Ltd currently have 8 directors, including Deepak Mohan, Sunil Attavar Cajaten, Ann Valerie Sunil Attavar and others.